Skip to content
Review Open access

Endogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction

Aug 2026 · Neuroglia · Vol 7, pp. 29 · 0 citations · 168 references

TL;DR

This framework suggests that effective therapeutic strategies may require restoration of physiological regulatory networks rather than targeting individual neurotoxic molecules in isolation, and facilitates the development of earlier biomarkers and more effective interventions aimed at preserving neuronal homeostasis and preventing progressive neurological dysfunction.

Abstract

Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neurotoxic when the regulatory mechanism involved in their production, metabolism, compartmentalization and clearance are disrupted. This shift underlies the basis of endogenous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neurotoxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mitochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neuronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeostasis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework suggests that effective therapeutic strategies may require restoration of physiological regulatory networks rather than targeting individual neurotoxic molecules in isolation. A systems-level understanding of endogenous neurotoxicity may therefore facilitate the development of earlier biomarkers and more effective interventions aimed at preserving neuronal homeostasis and preventing progressive neurological dysfunction.

Read PDF

Similar papers

Review Aug 2026

Immune-mediated excitotoxicity in brain disorders.

The concept of excitotoxicity is extended beyond glutamate receptor overactivation to include innate and adaptive immune pathways, introducing the framework of immune-mediated excitotoxicity and defining three hallmarks - feedback, stressor and chronicity - as organizing principles of this paradigm.

Josef Shin, C. Vogelaar, Stefan Bittner et al. · 0 citations
Review Open access Sep 2026

Common metabolic, environmental, and molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders

This review critically evaluates the experimental, epidemiological, and mechanistic evidence linking early-life metabolic and environmental insults with the establishment of latent vulnerability and proposes that this status may remain clinically silent for decades until activated by aging and cumulative stressors, ult...

A. S. Vallés, Francisco J. Barrantes · 0 citations
Editorial Open access Sep 2026

Mitochondrial Crossroads in Neurobiology: From Cellular Vulnerability to Therapeutic Opportunity

Overall, this Collection positions mitochondrial biology as a mechanistic framework connecting metabolic dysfunction, cellular stress, neuroinflammation, and neuronal degeneration, and supports its development as a therapeutic target for disease-modifying interventions in neurological disorders.

Rita Valenzuela, A. I. Rodriguez-Perez · 0 citations
Review Open access Aug 2026

Glutathione Biology in Neurodegenerative and Metabolic Diseases: Molecular Mechanisms, Pathophysiological Roles, and Therapeutic Perspectives

Glutathione should not be viewed as a universal therapeutic target; instead, glutathione should be perceived as an important factor contributing to cellular resilience and able to help other disease-specific interventions.

Grażyna Gromadzka, M. Kąkol, Magdalena Klimkiewicz et al. · 0 citations
Review Open access Aug 2026

From metabolism to neurodegeneration: how microglial functional reprogramming drives neurodegenerative diseases

A microglial immunometabolic trajectory framework is proposed in which metabolic states are viewed as branching and potentially reversible determinants of cellular function rather than fixed stages of a universal disease pathway.

Qiao-Qiao Cui, Ke Zheng, Qi-Yun Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.